Myron W. Shulgan
Independent DirectorMr. Myron W. Shulgan, KC, is Independent Director of Drugs Made In America Acquisition II Corp. from September 24, 2025. He is Independent Director of Drugs Made In America Acquisition Corp. since January 2025. Mr. Shulgan is a lawyer who has years of trial experience. He was a partner at Strosberg Sasso Sutts LLP from 2015 to 2023. Early in his career he worked as a federally appointed drug prosecutor for three years where he prosecuted individuals charged with drug related offences. During this period he developed his trial skills. Since then he has developed a trial practice during which he has represented corporations and individuals involved in complex commercial litigation, construction claims, banking disputes and other business related matters in trials and appeals in all levels of Courts in Canada including the Supreme Court of Canada. Mr. Shulgan has acted for and counselled clients in the manner in which they could navigate the maze of laws in highly regulated businesses to assist them in achieving their goals to ensure that they comply with their government mandated obligations. Mr. Shulgan received a bachelor of arts degree in political science and a bachelor of law degree from the University of Windsor. Mr. Shulgan was an associate at Strosberg Wingfiled Sasso from 2024 to 2025. Mr. Shulgan was associated with Myron Shulgan Professional Corporation from 2015-2024.
Positions
- Company NameDrugs Made In America Acquisition Corp.Stock CodeDMAAPositionIndependent DirectorRelated Securities
- Company NameDrugs Made In America Acquisition II Corp.Stock CodeDMIIPositionIndependent DirectorRelated Securities
